Spdr S&p Pharmaceuticals Etf ETF Forecast

Sell candidate since Jun 01, 2026 Loss -1.87%

The SPDR S&P Pharmaceuticals ETF price gained 1.10% on the last trading day (Wednesday, 3rd Jun 2026), rising from $55.70 to $56.32. During the last trading day the ETF fluctuated 1.44% from a day low at $55.54 to a day high of $56.34. The price has risen in 6 of the last 10 days and is up by 0.9% over the past 2 weeks. Volume fell on the last day by -94 thousand shares and in total, 117 thousand shares were bought and sold for approximately $6.57 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The ETF lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $54.99 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the ETF is expected to rise 8.90% during the next 3 months and, with a 90% probability hold a price between $59.88 and $67.77 at the end of this 3-month period.

XPH Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The ETF should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The SPDR S&P Pharmaceuticals ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the ETF. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $57.52 and $57.95. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 06, 2026, and so far it has fallen -7.22%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The ETF had a Golden Star Signal on Tuesday, July 08, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals finds support from accumulated volume at $55.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the ETF moved $0.80 (1.44%) between high and low. For the last week, the ETF has had daily average volatility of 1.28%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (XPH) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect SPDR S&P Pharmaceuticals ETF to open at $56.07, and during the day (based on 14 day Average True Range), to move between $55.80 and $56.83, which gives a possible trading interval of +/-$1.03 (+/-1.84%) up or down from last closing price. If SPDR S&P Pharmaceuticals ETF takes out the full calculated possible swing range there will be an estimated 1.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $56.61 (0.52%) than the support at $55.81 (0.90%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is SPDR S&P Pharmaceuticals ETF ETF A Buy?

The SPDR S&P Pharmaceuticals ETF holds several negative signals and despite the positive trend, we believe SPDR S&P Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this ETF.

Current score: -2.594 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $56.07 ( 0.444%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk